ADVERTISEMENT
Get Started
  • About Homebase Tv | Hbtvghana.com
  • Advertise
  • Broadcast Live
  • Disclaimer
  • Privacy & Policy
  • Terms and Conditions
  • Vacancies
  • Contact Us – Connect With Us
Homebase Tv - Hbtvghana.com
  • Home
  • General News
  • Business News
  • Health
  • Life & Style
  • Politics
    • Press Release
    • Parliament
  • Sports
No Result
View All Result
  • Home
  • General News
  • Business News
  • Health
  • Life & Style
  • Politics
    • Press Release
    • Parliament
  • Sports
No Result
View All Result
Homebase Tv - Hbtvghana.com
No Result
View All Result
ADVERTISEMENT
ADVERTISEMENT

First malaria treatment for babies approved for use

Tue, Jul 8 2025 11:32 PM
in Ghana General News, Health
first malaria treatment for babies approved for use
0
SHARES
0
VIEWS
Share on FacebookShare on TwitterShare on TelegramShare on Whatsapp
ADVERTISEMENT
image 624

The first malaria treatment suitable for babies and very young children has been approved for use.

It’s expected to be rolled out in African countries within weeks.

Until now, there have been no approved malaria drugs specifically for babies.

Instead, they have been treated with versions formulated for older children, which presents a risk of overdose.

Half a million deaths in 2023

In 2023 – the year for which the most recent figures are available – malaria was linked to around 597,000 deaths.

Almost all of the deaths were in Africa, and around three-quarters of them were children under five years old.

ReadAbout

Africa Film Finance Forum unlocks path to $20bn film economy

As the world reconfigures, can Africa claim its economic power?

Nigeria’s Dangote refinery plans 1.6 mln barrels fuel storage tanks in Namibia, sources say

Malaria treatments for children do exist, but until now, there was none specifically for the very youngest babies and small children, who weigh less than 4.5kg or around 10lb.

Instead, they have been treated with drugs designed for older children.

But that presents risks, as doses for these older children may not be safe for babies, whose liver functions are still developing and whose bodies process medicines differently.

Experts say this has led to what is described as a “treatment gap”.

Now, a new medicine, developed by the drug company Novartis, has been approved by the Swiss authorities and is likely to be rolled out in regions and countries with the highest rates of malaria within weeks.

Novartis is planning to introduce it on a largely not-for-profit basis.

The smallest and most vulnerable

The company’s chief executive, Vas Narasimhan, says this is an important moment.

“For more than three decades, we have stayed the course in the fight against malaria, working relentlessly to deliver scientific breakthroughs where they are needed most.

“Together with our partners, we are proud to have gone further to develop the first clinically proven malaria treatment for newborns and young babies, ensuring even the smallest and most vulnerable can finally receive the care they deserve.”

The drug, known as Coartem Baby or Riamet Baby in some countries, was developed by Novartis in collaboration with the Medicines for Malaria Venture (MMV), a Swiss-based not-for-profit organisation initially backed by the British, Swiss and Dutch Governments, as well as the World Bank and the Rockefeller Foundation.

Eight African nations also took part in the assessment and trials of the drug and they are expected to be among the first to access it.

Martin Fitchet, CEO of MMV, says this is another important step on the road towards ending the huge toll taken by malaria.

“Malaria is one of the world’s deadliest diseases, particularly among children. But with the right resources and focus, it can be eliminated.

“The approval of Coartem Baby provides a necessary medicine with an optimised dose to treat an otherwise neglected group of patients and offers a valuable addition to the antimalarial toolbox.”

Dr Marvelle Brown, associate professor at the University of Hertfordshire’s School of Health, Medicine and Life Sciences, says this should be seen as a major breakthrough in saving the lives of babies and young children.

“The death rate for malarial infections, particularly in sub-Saharan Africa, is extremely high – over 76% of deaths occur in children under five years old.

“An increase in death from malaria is further compounded in babies born with sickle cell disease, primarily due to a weak immune system.

“From a public health perspective, Novartis making this not-for-profit can help with reducing inequality in access to healthcare.”

DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.

DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.

  • President Commissions 36.5 Million Dollars Hospital In The Tain District
  • You Will Not Go Free For Killing An Hard Working MP – Akufo-Addo To MP’s Killer
  • I Will Lead You To Victory – Ato Forson Assures NDC Supporters

Visit Our Social Media for More

About Author

c16271dd987343c7ec4ccd40968758b74d64e6d6c084807e9eb8de11a77c1a1d?s=150&d=mm&r=g

hbtvghana

See author's posts

Discover interesting ones too

GUSA Champions Ghana’s Pride at 2025 FISU World Games in Germany

GUSA Champions Ghana’s Pride at 2025 FISU World Games in Germany

0
Africa Film Finance Forum unlocks path to $20bn film economy

Africa Film Finance Forum unlocks path to $20bn film economy

0

Bright Simons: Ghana and Nigeria are early victims of new US visa restrictions policy

Trade Minister inaugurates new GIPC board, tasks it to bolster investment drive

Today’s Front pages: Thursday, July 10, 2025

As the world reconfigures, can Africa claim its economic power?

Government appoints Ken Thompson as Chairman of ADB

DopeNation out with 3rd studio album GhanaPiano (The Album)

Abstention is complicity – Minority caucus blasts gov’t over LGBTQ vote

Gov’t betrays its own promises on LGBTQ – Samuel Jinapor fires over UN abstention

  • Ghana and Japan agree to pursue UN Security Council reforms

    Ghana and Japan agree to pursue UN Security Council reforms

    0 shares
    Share 0 Tweet 0
  • I resigned because of Prez. Mahama, NDC – former GBA President

    0 shares
    Share 0 Tweet 0
  • Rastafarian student Oheneba Nkrabea graduates from GIS after Achimota saga

    0 shares
    Share 0 Tweet 0
  • We slept in the same bed, but Ken Ofori-Atta’s legacy betrayed our hope – Frank Adu Jnr

    0 shares
    Share 0 Tweet 0
  • Western Region police arrest 44 suspects in major ‘galamsey’ raid

    0 shares
    Share 0 Tweet 0
ADVERTISEMENT
ADVERTISEMENT

Follow Homebase Tv

  • About Homebase Tv | Hbtvghana.com
  • Advertise
  • Broadcast Live
  • Disclaimer
  • Privacy & Policy
  • Terms and Conditions
  • Vacancies
  • Contact Us – Connect With Us

© 2014 Total Enjoyment & Proper News

No Result
View All Result

© 2014 Total Enjoyment & Proper News

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT

Add New Playlist

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.